Cargando…
Is Gut Microbiota Dysbiosis a Predictor of Increased Susceptibility to Poor Outcome of COVID-19 Patients? An Update
The scientific knowledge already attained regarding the way severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects human cells and the clinical manifestations and consequences for Coronavirus Disease 2019 (COVID-19) patients, especially the most severe cases, brought gut microbiota int...
Autores principales: | Ferreira, Carolina, Viana, Sofia D., Reis, Flávio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824665/ https://www.ncbi.nlm.nih.gov/pubmed/33379162 http://dx.doi.org/10.3390/microorganisms9010053 |
Ejemplares similares
-
ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities – Role of gut microbiota dysbiosis
por: Viana, Sofia D., et al.
Publicado: (2020) -
Gut Microbiota Dysbiosis–Immune Hyperresponse–Inflammation Triad in Coronavirus Disease 2019 (COVID-19): Impact of Pharmacological and Nutraceutical Approaches
por: Ferreira, Carolina, et al.
Publicado: (2020) -
Dysbiosis of the gut microbiota as a susceptibility factor for Kawasaki disease
por: Teramoto, Yoshiki, et al.
Publicado: (2023) -
Are gut dysbiosis, barrier disruption, and endotoxemia related to adipose tissue dysfunction in metabolic disorders? Overview of the mechanisms involved
por: Rosendo-Silva, Daniela, et al.
Publicado: (2023) -
Dysbiosis of the gut microbiota in disease
por: Carding, Simon, et al.
Publicado: (2015)